• FirefoxUpgrade to the new Firefox »
  •  Dow Up 0.04% Nasdaq Up 0.27%

    Gilead Sciences Inc. (GILD)

    -NasdaqGS
    108.15 Up 2.61(2.47%) 11:57AM EST - Nasdaq Real Time Price
    Add to Portfolio
    Prev Close:105.54
    Open:105.43
    Bid:107.81 x 1400
    Ask:107.84 x 600
    1y Target Est:126.17
    Beta:1.11
    Earnings Date:Feb 2 - Feb 6 (Est.)
    Day's Range:104.64 - 108.25
    52wk Range:63.50 - 116.83
    Volume:9,582,173
    Avg Vol (3m):15,014,500
    Market Cap:163.16B
    P/E (ttm):19.27
    EPS (ttm):5.61
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Related Video

    Featured on Yahoo Finance

    Headlines

    » More Headlines for GILD

    Comparison

    Symbol% ChgMkt Cap
    GILDUp 2.47%163.16B
    GSKUp 0.32%104.41B
    PFEDown 0.09%201.24B
    RHHBYDown 6.64%234.08B

    Key Statistics

    Forward P/E (1 yr):10.69
    P/S (ttm):7.69
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-14) :7.93
    Quarterly EPS Est (Dec-14) :2.26
    Mean Recommendation*:1.7
    PEG Ratio (5 yr expected):0.54

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines for the treatment of life threatening diseases in North America, South America, Europe, and the Asia-Pacific. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback